期刊文献+

斑点型锌指结构蛋白在膀胱癌中的表达 被引量:5

Expression of speckle-type POZ protein in bladder cancer
下载PDF
导出
摘要 目的 探讨斑点型锌指结构蛋白(SPOP)在膀胱癌中的表达及意义.方法 选择清华大学第一附属医院2012年12月至2014年3月行膀胱根治术及经尿道切除的膀胱尿路上皮癌标本32例,另选癌旁距离肿瘤组织5 cm以上的正常组织及部分前列腺手术时取出的正常膀胱黏膜20例作为正常对照,采用免疫组织化学法和蛋白质印迹法检测膀胱癌组织与正常膀胱组织中SPOP表达情况.采用蛋白免疫印迹法定性检测膀胱癌细胞株5637、T24、J82及正常膀胱细胞株SV-HUC-1中SPOP的表达水平.结果 SPOP在膀胱癌组织中表达阳性率为65.6% (21/32),低于正常膀胱组织[100% (20/20)],膀胱癌组织中SPOP表达水平明显低于正常膀胱组织(0.21 ±0.08比0.73 ±0.06,P<0.01).膀胱癌细胞株5637、T24、J82中SPOP表达水平均明显低于正常膀胱细胞株SV-HUC-1(0.43 ±0.05、0.14 ±0.06、0.03±0.01比0.72±0.14,P<0.01).结论 SPOP可能是一种膀胱癌的分子标记物,与膀胱癌的发生、发展相关. Objective To explore the expression and significance of speckle-type POZ protein (SPOP) in bladder cell cancer.Methods Totally 32 samples of bladder carcinoma and 20 samples of normal bladder either from mucosa tissue 〉 5 cm outside of the cancer tissue or from the normal bladder tissue of prostate operation were selected.The expression of SPOP in bladder cancer and normal bladder tissues were detected by immunohistochemistry and Western blot;the expressions of SPOP in bladder cancer lines 5 637,T24,J82 and normal bladder cell line SV-HUC-1 were also detected by Western blot.Results The positive rate of SPOP expression in bladder cancer was 65.6% (21/32),lower than that in normal bladder tissue 100% (20/20);the expression level of SPOP was significantly lower in bladder cancer tissues than that in normal bladder tissue (0.21 ±0.08 vs 0.73 ± 0.06),and was significantly lower in bladder cancer cell lines 5 637,T24,J82 than that in normal bladder cell line SV-HUC-1 (0.43±0.05,0.14±0.06,0.03±0.01 vs0.72±0.14)(P〈0.01).Conclusion SPOP may be a molecular bio-marker for bladder cancer,and associated with the development and progression of bladder cancer.
出处 《中国医药》 2015年第7期1071-1074,共4页 China Medicine
关键词 膀胱肿瘤 斑点型锌指结构蛋白 泛素化 Bladder cancer Speckle-type POZ protein Ubiquitination
  • 相关文献

参考文献27

  • 1Singh PK, Srivastava AK, Dalela D, et al. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma[J]. Immunobiology, 2015,220(1):68-73.
  • 2石泓哲,田军,李长岭.八宝丹辅助羟基喜树碱膀胱灌注预防浅表性膀胱癌术后复发的疗效分析[J].中国医药,2013,8(5):655-656. 被引量:4
  • 3孙然,王凯臣,孙鸿燕,孔祥波,丛宪玲.膀胱癌患者癌组织和尿沉淀细胞抑癌基因DNA甲基化研究[J].中华实验外科杂志,2012,29(10):2054-2056. 被引量:8
  • 4van Rhijn BW, Catto JW, Goebell PJ, et al. Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice[J]. Urol Oncol, 2014,32(7):1078-1087.
  • 5Kim MS, Je EM, Oh JE, et al. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric andcolorectal cancers[J]. APMIS, 2013,121(7):626-633.
  • 6Kim B, Nam HJ, Pyo KE, et al. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex[J]. Biochem Biophys Res Commun, 2011,415(4):720-726.
  • 7卢国栋,袁明振,俎树禄,赵升田.SPOP蛋白在肾透明细胞癌中的表达[J].山东大学学报(医学版),2012,50(7):74-77. 被引量:6
  • 8Li G, Ci W, Karmakar S, et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer[J]. Cancer Cell, 2014,25(4):455-468.
  • 9Kulkarni P, Shiraishi T, Rajagopalan K, et al. Cancer/testis antigens and urological malignancies[J]. Nat Rev Urol, 2012,9(7):386-396.
  • 10Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63(1):11-30.

二级参考文献43

共引文献427

同被引文献33

  • 1Ye F,Wang L, Castillo-Martin M , e*t al. Biomarkers for bladdercancer management : present ami futuref J] . Am J Clin Exp Urol,2014, 2(l):i-I4.
  • 2Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 | J ]. CACancer J Clin, 2014,64(1) : 9-29.
  • 3Burger M, Catto JW, Dalbagni G, et al. Epidemiology and riskfactors of urothelial bladder cancer[ J]. Eur Urol,2013,63(2):234-241.
  • 4Lindsey NM,John JT,Peter GS,et al. Role of ubiquitin ligasesand the proteasome in oncogenesis : novel targets for anticancertherapies[ J] . J Clin Oncol, 2013, 31(9) :1231-1238.
  • 5Kim MS,Je EM, Oh JE, et al. Mutational and expressions! ana-lyses of SPOP,a candidate tumor suppressor gene,in prostate,gastric and colorectal cancers[ J]. APMIS, 2013, 121(7) : 626-633.
  • 6Kim B, Nam HJ, Pyo KE, et al. Breast cancer metastasis sup-pressor 1 ( BRMS1) is destabilized by the Cul3-SPOP E3 ubiq-uitin ligase complex[ J]. Biochem Biophys Res Commun, 2011,415(4) : 720-726.
  • 7Huang Y, Tan N, Jia D,et al. Speckle-type POZ protein is nega-tively associated with malignancies and inhibits cell proliferationand migration in liver cancer[ J]. Tumour Biol, 2015,36( 12):9753-9761.
  • 8Zhang P, Gao K, Jin X,at el. Endometrial cancer-associatedmutants of SPOP are defective in regulating estrogen receptor-aprotein turnover [ J/OL] . Cell Death Dis, 2015 [ 2015-10-15 ].http ://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4385925.
  • 9Singh PK, Srivastava AK, Dalela D, et al. Frequent expressionof zinc-finger protein ZNF165 in human urinary bladdertransitional cell carcinoma[ J] . Immunobiology, 2015,220(1):68-73.
  • 10van Rhijn BW, Catto JW, Goebell PJ, et al. Molecular markersfor urothelial bladder cancer prognosis : toward implementation inclinical practice[ J]. Urol Oncol, 2014,32(7) : 1078-1087.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部